$VICR

Vicor (VICR) Could Be 48% Undervalued After Higher Q2 Revenue And Net Income

Simply Wall St highlighted Vicor (VICR) after its Q2 2026 results. The company reported revenue of $143.35M and net income of $49.77M, with higher EPS year over year. The stock fell 8.8% in a day and 35.5% in a month. A “most popular narrative” cites fair value of $406.25 versus $211.01, while a DCF model estimates $179.76.

Original reporting
Published Jul 26, 2026, 9:34 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 27, 2026, 12:24 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$VICR
Neutral
medium confidence
Mentioned
$VICR
Relevance
4/10
alphai data visualization · based on simplywall.st
Decision brief

The 30-second read

$VICRNeutralLow
01

Why it matters

The trading focus is the disconnect between reported higher revenue and net income and the stock’s sharp recent decline, with cited risks that could justify a lower multiple.

02

Market read

Valuation framing after Q2 results may influence dip-buying versus continued caution, but the piece is primarily analytical rather than a new catalyst.

03

What to watch

The article flags book-to-bill below 1 and litigation-driven licensing income, but does not quantify backlog, cash conversion, or the durability of licensing, which could dominate the valuation debate.

Relevance 4/10Novelty 4/10Timing: after-hours/next-session positioning following Q2 results and the immediate post-report selloff

Background

Simply Wall St discusses Vicor’s Q2 2026 results and contrasts two valuation approaches: an analyst-target-based fair value versus its own DCF cash-flow estimate.

Company-level read

Ticker impact

$VICRNeutralMedium confidence
Context

Vicor reported Q2 2026 revenue of $143.35M and net income of $49.77M, yet the stock is down 8.8% today and 35.5% over a month.

Expected impact

Near-term trading is likely to hinge on whether investors buy the AI power-demand narrative versus the weaker book-to-bill and cash-flow valuation.

Evidence & confidence

The only concrete, decision-relevant datapoints provided are the Q2 financial figures and the two valuation frameworks, plus cited risks (book-to-bill below 1, litigation-driven licensing income). No new guidance or catalyst beyond the reported results is disclosed.

Market effects

If the AI data-center power delivery demand thesis is believed, it supports sentiment for high-power converter and vertical power supply suppliers; if not, it raises skepticism about near-term order momentum.

No specific regional impact is described beyond general US-listed equity sentiment.

AI infrastructure power demand is global, but the article provides no region-specific orders or regulatory developments.

Counterpoint

The DCF-based cash-flow value ($179.76) versus the narrative fair value ($406.25) suggests the market may be discounting order quality and cash conversion, not just near-term earnings.

Key entities

  • Vicor

    US-listed power delivery solutions provider reporting Q2 2026 revenue and net income, and facing a valuation debate after the stock selloff.

Related articles

$VICRMedAI 8/10

Vicor (VICR) Q2 2026 Earnings Call Transcript

Vicor’s Q2 2026 earnings call reported product and royalty revenue of $143.4M, up 26.9% sequentially and 1.6% year over year. Advanced products revenue rose to $94.2M. Net income was $49.8M, GAAP diluted EPS $1.40, and cash was $453.6M. The company guided for nearly 10% Q3 revenue growth and over $600M 2026 revenue, citing capacity increases and licensing assumptions.

$VICRMed

Vicor Corp (VICR) Q2 2026 Earnings Call Highlights: Strong Revenue Growth

Vicor Corp said a new license agreement will bring $5 million quarterly payments in year one and $10 million in year two, with $15 million contributing to Q2 revenue and additional revenue recognition expected in Q3 and subsequent quarters. Management also discussed fab capacity expansion to support a $2.5 billion revenue goal and said backlog growth stems mainly from existing customer demand.

$VICRMed

VICOR CORP (VICR): Results of Operations and Financial Condition

VICOR CORP (VICR) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 d115827dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 NEWS RELEASE FINANCIAL NEWS BRIEF July 21, 2026 For Immediate Release Vicor Corporation Reports Results for the Second Quarter Ended June 30, 2026 Andover, Mass., July 21, 2026 (GLOBE NEWSWIRE) — Vicor Corporation (NASDAQ:

$VICRMedAI 8/10

Vicor (NASDAQ:VICR) Reaches New 12

Vicor (NASDAQ:VICR) reached a new 52-week high on Wednesday, trading up to $334.62 and last at $332.95 versus a prior close of $267.99, with 1,586,277 shares traded. The stock also followed its April 21 quarterly results: EPS $0.44 vs $0.40 expected; revenue $112.97M vs $109.05M. Analysts cited mixed ratings and targets.

$AEHRHighAI 9/10

Here's Why Aehr Test Systems Popped Higher Today

Aehr Test Systems shares rose about 16% on the day, after Vicor unexpectedly raised its second-quarter revenue guidance, according to Vicor. Vicor cited higher product revenues and royalties from an additional licensee. Aehr, which sells wafer-level burn-in test equipment for power semiconductors and AI processors, reported a $41M hyperscaler order, lifting orders to over $92M in fiscal 2026 H2.